Charlotte Dalba

511 total citations
10 papers, 391 citations indexed

About

Charlotte Dalba is a scholar working on Molecular Biology, Epidemiology and Genetics. According to data from OpenAlex, Charlotte Dalba has authored 10 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Epidemiology and 4 papers in Genetics. Recurrent topics in Charlotte Dalba's work include Virus-based gene therapy research (4 papers), Immunotherapy and Immune Responses (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Charlotte Dalba is often cited by papers focused on Virus-based gene therapy research (4 papers), Immunotherapy and Immune Responses (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Charlotte Dalba collaborates with scholars based in France, United States and Portugal. Charlotte Dalba's co-authors include David Klatzmann, Bertrand Bellier, Noriyuki Kasahara, François–Loïc Cosset, Delphine Desjardins, Frédéric Tangy, Anne-Catherine Fluckiger, Christopher R. Logg, Christophe Huret and Pierre Garrone and has published in prestigious journals such as Science Translational Medicine, Biotechnology and Bioengineering and Vaccine.

In The Last Decade

Charlotte Dalba

10 papers receiving 383 citations

Peers

Charlotte Dalba
Mariarosaria Naddeo Italy
А. А. Гражданцева Russia
Virginia Ammendola Italy
R A Bhat United States
David C. Whitacre United States
Jun Mukaigawa Japan
Wai-Ping Woo Australia
Aryn A. Price United States
Andrew G. Cawthon United States
Ashrafali Mohamed Ismail United States
Mariarosaria Naddeo Italy
Charlotte Dalba
Citations per year, relative to Charlotte Dalba Charlotte Dalba (= 1×) peers Mariarosaria Naddeo

Countries citing papers authored by Charlotte Dalba

Since Specialization
Citations

This map shows the geographic impact of Charlotte Dalba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotte Dalba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotte Dalba more than expected).

Fields of papers citing papers by Charlotte Dalba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotte Dalba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotte Dalba. The network helps show where Charlotte Dalba may publish in the future.

Co-authorship network of co-authors of Charlotte Dalba

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotte Dalba. A scholar is included among the top collaborators of Charlotte Dalba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotte Dalba. Charlotte Dalba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kirchmeier, Marc, Anne-Catherine Fluckiger, Tanvir Ahmed, et al.. (2013). Enveloped Virus-Like Particle Expression of Human Cytomegalovirus Glycoprotein B Antigen Induces Antibodies with Potent and Broad Neutralizing Activity. Clinical and Vaccine Immunology. 21(2). 174–180. 65 indexed citations
2.
Huret, Christophe, Delphine Desjardins, Béatrice Levacher, et al.. (2012). Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice. Vaccine. 31(11). 1540–1547. 26 indexed citations
3.
Rodrigues, Ana F., Rute Castro, Charlotte Dalba, et al.. (2011). Down-regulation of CD81 in human cells producing HCV-E1/E2 retroVLPs. BMC Proceedings. 5(S8). P72–P72. 3 indexed citations
4.
Rodrigues, Ana F., Charlotte Dalba, David Klatzmann, et al.. (2011). Down‐regulation of CD81 tetraspanin in human cells producing retroviral‐based particles: Tailoring vector composition. Biotechnology and Bioengineering. 108(11). 2623–2633. 8 indexed citations
5.
Garrone, Pierre, Anne-Catherine Fluckiger, Philippe Mangeot, et al.. (2011). A Prime-Boost Strategy Using Virus-Like Particles Pseudotyped for HCV Proteins Triggers Broadly Neutralizing Antibodies in Macaques. Science Translational Medicine. 3(94). 94ra71–94ra71. 115 indexed citations
6.
Bellier, Bertrand, Christophe Huret, Delphine Desjardins, et al.. (2009). DNA vaccines expressing retrovirus-like particles are efficient immunogens to induce neutralizing antibodies. Vaccine. 27(42). 5772–5780. 31 indexed citations
7.
Desjardins, Delphine, Christophe Huret, Charlotte Dalba, et al.. (2009). Recombinant retrovirus‐like particle forming DNA vaccines in prime‐boost immunization and their use for hepatitis C virus vaccine development. The Journal of Gene Medicine. 11(4). 313–325. 25 indexed citations
8.
Dalba, Charlotte, Bertrand Bellier, Noriyuki Kasahara, & David Klatzmann. (2007). Replication-competent Vectors and Empty Virus-like Particles: New Retroviral Vector Designs for Cancer Gene Therapy or Vaccines. Molecular Therapy. 15(3). 457–466. 33 indexed citations
9.
Dalba, Charlotte, David Klatzmann, Christopher R. Logg, & Noriyuki Kasahara. (2005). Beyond Oncolytic Virotherapy: Replication-Competent Retrovirus Vectors for Selective and Stable Transduction of Tumors. Current Gene Therapy. 5(6). 655–667. 39 indexed citations
10.
Bellier, Bertrand, Charlotte Dalba, Delphine Desjardins, et al.. (2005). DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant. Vaccine. 24(14). 2643–2655. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mariarosaria Naddeo Breakdown of academic impact, for papers by А. А. Гражданцева Breakdown of academic impact, for papers by Virginia Ammendola Breakdown of academic impact, for papers by R A Bhat Breakdown of academic impact, for papers by David C. Whitacre Breakdown of academic impact, for papers by Jun Mukaigawa Breakdown of academic impact, for papers by Wai-Ping Woo Breakdown of academic impact, for papers by Aryn A. Price Breakdown of academic impact, for papers by Andrew G. Cawthon Breakdown of academic impact, for papers by Ashrafali Mohamed Ismail
Rankless by CCL
2026